Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

An ethnobotanical survey of medicinal plants used in Rwanda for voluntary depigmentation.

Auteurs : Kamagaju L, Bizuru E, Minani V, Morandini R, Stévigny C, Ghanem G, Duez P
Jaar : 2013
Journal : J Ethnopharmacol
Volume : 150(2)
Pagina's : 708-17

Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Auteurs : Aftimos P, Wiedig M, Langouo Fontsa M, Awada A, Ghanem G, Journe F
Jaar : 2013
Journal : Int J Oncol
Volume : 43(3)
Pagina's : 919-26

Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment.

Auteurs : Kamagaju L, Morandini R, Bizuru E, Nyetera P, Nduwayezu JB, Stévigny C, Ghanem G, Duez P
Jaar : 2013
Journal : J Ethnopharmacol
Volume : 146(3)
Pagina's : 824-34

Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.

Auteurs : Kindt N, Laurent G, Nonclercq D, Journe F, Ghanem G, Duvillier H, Gabius HJ, Lechien J, Saussez S
Jaar : 2013
Journal : Int J Oncol
Volume : 43(1)
Pagina's : 185-93

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients.

Auteurs : El Hajj P, Journe F, Wiedig M, Laios I, Sales F, Galibert MD, Van Kempen LC, Spatz A, Badran B, Larsimont D, Awada A, Ghanem G
Jaar : 2013
Journal : Br J Cancer
Volume : 108(8)
Pagina's : 1641-7

Electron paramagnetic resonance spectrometry and imaging in melanomas: comparison between pigmented and nonpigmented human malignant melanomas.

Auteurs : Godechal Q, Ghanem G, Cook MG, Gallez B
Jaar : 2013
Journal : Mol Imaging
Volume : 12(4)
Pagina's : 218-23

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Auteurs : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Jaar : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pagina's : 394-400

Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.

Auteurs : Anghel SI, Correa-Rocha R, Correa-Rochal R, Budinska E, Boligan KF, Boliganl KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem G, Fisher DE, Lévy F, Delorenzi M, Piguet V
Jaar : 2012
Journal : Pigment Cell Melanoma Res
Volume : 25(4)
Pagina's : 482-7

Has removal of excess cysteine led to the evolution of pheomelanin? Pheomelanogenesis as an excretory mechanism for cysteine.

Auteurs : Galván I, Ghanem G, Møller AP
Jaar : 2012
Journal : Bioessays
Volume : 34(7)
Pagina's : 565-8

MDM4 is a key therapeutic target in cutaneous melanoma.

Auteurs : Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC
Jaar : 2012
Journal : Nat. Med.
Volume : 18
Pagina's : 1239-47

Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.

Auteurs : Herraiz C, Journe F, Ghanem G, Jiménez-Cervantes C, García-Borrón JC
Jaar : 2012
Journal : Int. J. Biochem. Cell Biol.
Volume : 44(12)
Pagina's : 2244-2252

Survey concerning exposure of staff to UV radiation at four Brussels hospitals.

Auteurs : Lam Hoai XL, André J, Del Marmol V, Ghanem G, Sales F, Vereecken P
Jaar : 2012
Journal : Ann Dermatol Venereol
Volume : 139(2)
Pagina's : 91-102

Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.

Auteurs : Desmedt C, Majjaj S, Kheddoumi N, Singhal SK, Haibe-Kains B, El Ouriaghli F, Chaboteaux C, Michiels S, Lallemand F, Journe F, Duvillier H, Loi S, Quackenbush J, Dekoninck S, Blanpain C, Lagneaux L, Houhou N, Delorenzi M, Larsimont D, Piccart-Gebhart M, Sotiriou C
Jaar : 2012
Journal : Clin Cancer Res
Volume : 18(4)
Pagina's : 1004-14

EORTC Melanoma Group achievements.

Auteurs : Testori A, Suciu S, Van Akkooi ACJ, Cook M, Ghanem G, Gurunathb RK, Keilholz U, Van Kempen L, Leyvraz S, Mihm M, Newton-Bishop J, Patel P, Robert C, Schadendorf D, Schaetzen G, Spatz A, De Vries E, Eggermont AM
Jaar : 2012
Journal : EJC Supplements
Volume : 9(2)
Pagina's : 112-119

Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.

Auteurs : Id Boufker H, Lagneaux L, Fayyad-Kazan H, Badran B, Najar M, Wiedig M, Ghanem G, Laurent G, Body JJ, Journe F
Jaar : 2011
Journal : Bone
Volume : 49(6)
Pagina's : 1219-31

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.

Auteurs : Journe F, Id Boufker H, Van Kempen L, Galibert MD, Wiedig M, Sales F, Theunis A, Nonclercq D, Frau A, Laurent G, Awada A, Ghanem G
Jaar : 2011
Journal : Br J Cancer
Volume : 105(11)
Pagina's : 1726-32

Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.

Auteurs : Herraiz C, Journe F, Abdel-Malek Z, Ghanem G, Jiménez-Cervantes C, García-Borrón JC
Jaar : 2011
Journal : Mol. Endocrinol.
Volume : 25(1)
Pagina's : 138-56

Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952.

Auteurs : Bouwhuis MG, Suciu S, Kruit W, Sales F, Stoitchkov K, Patel P, Cocquyt V, Thomas J, Liénard D, Eggermont AM, Ghanem G
Jaar : 2011
Journal : Eur. J. Cancer
Volume : 47(3)
Pagina's : 361-8

Tyrosinase related protein 1 (TYRP1 / gp75) in human cutaneous melanoma.

Auteurs : Ghanem G, Journe F
Jaar : 2011
Journal : Mol oncol
Volume : 5(2)
Pagina's : 150-155